Evidence map›Paper›PMID 39814070›Full record

ArticleJNCI cancer spectrum2025

Rethinking the rise of early-onset gastrointestinal cancers: a call to action.

Benjamin A Weinberg, Caitlin C Murphy, David R Freyer, K Leigh Greathouse, Jan K Blancato, Elena M Stoffel, Julia L Drewes, Anne Blaes, John M Salsman, Y Nancy You and 8 more

Abstract read
In one paragraph

Article in JNCI cancer spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Benjamin A WeinbergRuesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, United States.ORCID 0000-0002-0408-4817
Caitlin C MurphyDepartment of Health Promotion & Behavioral Sciences, UTHealth Houston School of Public Health, Houston, TX 77030, United States.ORCID 0000-0001-9365-0691
David R FreyerDepartments of Pediatrics, Medicine, and Population & Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90032, United States.ORCID 0000-0001-5280-990X
K Leigh GreathouseDepartment of Human Sciences and Design, Baylor University, Waco, TX 76706, United States.ORCID 0000-0002-6855-8516
Jan K BlancatoDepartment of Oncology, Georgetown University, Washington, DC 20007, United States.
Elena M StoffelDepartment of Internal Medicine, University of Michigan, Rogel Cancer Center, Ann Arbor, MI 48109, United States.
Julia L DrewesDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.
Anne BlaesMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, United States.ORCID 0000-0002-5433-4810
John M SalsmanWake Forest University School of Medicine & Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC 27157, United States.ORCID 0000-0003-2317-4006
Y Nancy YouDepartment of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 78701, United States.
Hannah AremHealthcare Delivery Research, MedStar Health Research Institute, Washington, DC 20010, United States.ORCID 0000-0002-5734-0810
Reetu MukherjiRuesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, United States.ORCID 0000-0001-7384-0498
Priyanka KanthDivision of Gastroenterology, MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC 20007, United States.ORCID 0000-0001-9303-1516
Xin HuGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, GA 30329, United States.ORCID 0000-0003-2747-9085
Anne FabrizioDivision of Colon & Rectal Surgery, MedStar Georgetown University Hospital, Washington, DC 20007, United States.
Marion L HartleyRuesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, United States.ORCID 0000-0001-5516-297X
Marios GiannakisDana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States.ORCID 0000-0001-9012-6982
John L MarshallRuesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, United States.ORCID 0000-0002-3449-2344

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the early 1990s, there has been a dramatic rise in gastrointestinal cancers diagnosed in patients under age 50 for reasons that remain poorly understood. The most significant change has been the increase in incidence rates of early-onset colorectal cancer, especially rates of left-sided colon and rectal cancers. Increases in gastric, pancreatic, and other gastrointestinal cancer diagnoses have further contributed to this trend. We formed a multidisciplinary Think Tank to develop a strategic, coordinated approach to studying early-onset gastrointestinal cancers. This area of research is challenging given multifactorial etiologies. We focused on epidemiology and the environment, the microbiome, and survivorship as key pillars to structure a research framework. We advocate a comprehensive strategy to (1) use existing biospecimens, especially those collected longitudinally, with correlation to exposures (the exposome); (2) standardize microbiome specimen collection and analyses of blood, tissue, and stool specimens to minimize contamination and biases; (3) prioritize mechanistic studies to evaluate findings from biomarker studies; and (4) explore the unique survivorship needs of this young population. These recommendations build upon prior efforts with the goal of streamlining research into this important field of study while minimizing redundant efforts. We hope that our findings serve as a clarion call to motivate others to discover why young individuals are being diagnosed with gastrointestinal cancers at such an alarming rate and how to best support those who have been diagnosed.

Indexed as

Gastrointestinal NeoplasmsAge of OnsetColorectal NeoplasmsGastrointestinal MicrobiomeHumansIncidenceMiddle AgedSpecimen Handling

Identifiers

PMID39814070
PMCPMC11804804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.